IHU Hepatologie Lyon (@ihu_hepatolyon) 's Twitter Profile
IHU Hepatologie Lyon

@ihu_hepatolyon

The Lyon Hepatology Institute was created with the mission to meet the current challenges of chronic liver diseases.

ID: 1853777473298698240

linkhttps://www.ihu-hepatolyon.fr/en/homepage/ calendar_today05-11-2024 12:33:04

16 Tweet

13 Followers

89 Following

The Lancet Gastroenterology & Hepatology (@lancetgastrohep) 's Twitter Profile Photo

Linked Comment - Fabien Zoulim - Does siRNA-based therapy require pegylated interferon-alfa-2a to cure HBV infection? thelancet.com/journals/langa… #LiverTwitter #NoHep #HBV

Hep B Foundation (@hepbfoundation) 's Twitter Profile Photo

🧑🏾‍💻You're invited to attend the Bruce Witte Lecture online: "Understanding Viral Persistence to Cure Hepatitis B Virus Infection," ✨featuring Fabien Zoulim MD, PhD. Join us on 📅Wednesday, Nov. 20, 2024 at⏲️4 p.m. EDT

🧑🏾‍💻You're invited to attend the Bruce Witte Lecture online: "Understanding Viral Persistence to Cure Hepatitis B Virus Infection," ✨featuring Fabien Zoulim MD, PhD. 

Join us on 📅Wednesday, Nov. 20, 2024 at⏲️4 p.m. EDT
Armando Andres Roca Suarez (@andresroca) 's Twitter Profile Photo

Feeling very thankful to Charlotte Hernandez, Claire Verzeroli and Romain Parent for the opportunity to collaborate on this great project, now published in JHEP Reports. #HCC #livertwitter IHU Hepatologie Lyon jhep-reports.eu/article/S2589-…

Gut Journal (@gut_bmj) 's Twitter Profile Photo

#GUTImage from the paper by Roca Suarez Armando Andres Roca Suarez et al entitled "TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism" via bit.ly/3O86nzC @TestoniResearch Fabien Zoulim #HBV

#GUTImage from the paper by Roca Suarez <a href="/andresroca/">Armando Andres Roca Suarez</a> et al entitled

"TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism" via

bit.ly/3O86nzC

@TestoniResearch <a href="/FabienZoulim/">Fabien Zoulim</a> #HBV
The Lancet Gastroenterology & Hepatology (@lancetgastrohep) 's Twitter Profile Photo

Globally, only 13% of people living with chronic hepatitis B and 36% living with chronic hepatitis C have been diagnosed. It’s time for World Hepatitis Testing Week. New Comment from World Hepatitis Alliance - thelancet.com/journals/langa… #LiverTwitter #NoHep

European Liver Patients' Association (@europeliver) 's Twitter Profile Photo

Celebrating 75 Years of AASLD at #TLM24 in San Diego! 🇺🇸 🇪🇺 🇨🇦 ELPA is honored to join the global liver health community at The Liver Meeting 2024 (#TLM24) to celebrate the 75th anniversary of the American Association for the Study of Liver Diseases (AASLD)! Together with

Celebrating 75 Years of AASLD at #TLM24 in San Diego! 🇺🇸 🇪🇺 🇨🇦 

ELPA is honored to join the global liver health community at The Liver Meeting 2024 (#TLM24) to celebrate the 75th anniversary of the American Association for the Study of Liver Diseases (AASLD)! Together with
Vivian Ortiz (@vivianortizmd) 's Twitter Profile Photo

Kicking off #TLM24 with Basic Science Symposium! Sumera Ilyas and Yujin Hoshida leading the session on Metabolics In hepatobiliary malignancies. Come and hear great science. Mayo Clinic Gastroenterology & Hepatology AASLD #livertwitter

Kicking off #TLM24 with Basic Science Symposium! <a href="/SumeraIlyasMD/">Sumera Ilyas</a> and Yujin Hoshida leading the session on Metabolics In hepatobiliary malignancies. Come and hear great science. <a href="/MayoClinicGIHep/">Mayo Clinic Gastroenterology & Hepatology</a> <a href="/AASLDtweets/">AASLD</a> #livertwitter
IHU Hepatologie Lyon (@ihu_hepatolyon) 's Twitter Profile Photo

👏We are proud of our Director Fabien Zoulim who have been named on the Clarivate Highly Cited Researchers List 2024! 👉Access the whole list: clarivate.com/highly-cited-r… #HighlyCited2024

👏We are proud of our Director <a href="/FabienZoulim/">Fabien Zoulim</a> who have been named on the <a href="/Clarivate/">Clarivate</a> Highly Cited Researchers List 2024!
👉Access the whole list: clarivate.com/highly-cited-r…
#HighlyCited2024
IHU Hepatologie Lyon (@ihu_hepatolyon) 's Twitter Profile Photo

🆕Dans le cadre du Festival de la Santé Mondiale, le 16 Décembre 2024, le Prof. Massimo Levrero présentera notre IHU Hepatologie Lyon Everest dans les locaux de l'ISFA Université Lyon 1 👉Plus d'informations sur le programme complet et inscription : rhone.gouv.fr/Actualites/Fes…

🆕Dans le cadre du Festival de la Santé Mondiale, le 16 Décembre 2024, le Prof. Massimo Levrero présentera notre <a href="/IHU_HepatoLyon/">IHU Hepatologie Lyon</a> Everest dans les locaux de l'ISFA <a href="/UnivLyon1/">Université Lyon 1</a> 
👉Plus d'informations sur le programme complet et inscription : rhone.gouv.fr/Actualites/Fes…
IHU Hepatologie Lyon (@ihu_hepatolyon) 's Twitter Profile Photo

📅 Falk Symposium 240: Experimental #Hepatology Days. April 24-26 in Lyon. The deadline for the poster submission is January 15, 2025. More information below. 👇

📅 Falk Symposium 240: Experimental #Hepatology Days. April 24-26 in Lyon. 
The deadline for the poster submission is January 15, 2025.
More information below. 👇
SOS hépatites (@sos_hepatites) 's Twitter Profile Photo

🔥 Clap de fin pour notre Forum national 2024 ! Merci à tous nos partenaires, intervenants, participants, bénévoles, prestataires pour cette édition vraiment riche ! ✊ On ne lâche rien ! Restez à l’écoute, et on vous dit à 2025 à Dijon ! 😉

🔥 Clap de fin pour notre Forum national 2024 !  
Merci à tous nos partenaires, intervenants,  participants, bénévoles, prestataires pour cette édition vraiment riche !    
✊ On ne lâche rien !   
Restez à l’écoute, et on vous dit à 2025 à Dijon ! 😉
IHU Hepatologie Lyon (@ihu_hepatolyon) 's Twitter Profile Photo

📣The IHU Everest is leaving the X social media platform. You can now follow our news on #Bluesky 👉bsky.app/profile/ihuhep…